Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The “mitotic spindle organizing protein 2B pseudogene” (ENSG00000278337) is a genomic sequence categorized as a pseudogene. Unlike the functional MZT2B gene, which encodes a protein required for the assembly of the gamma-tubulin ring complex at the centrosome and contributes to mitotic spindle formation, the pseudogene is generally non-coding and does not produce a functional protein. Pseudogenes originate from protein-coding genes but acquire disabling mutations preventing protein expression, and their biological significance is usually limited unless specifically shown to have regulatory RNA function. No therapeutic drug targets, disease associations, or biological functions have been documented for this pseudogene.
None relevant; no known mechanism for therapeutic modulation applies to pseudogenes
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitotic spindle organizing protein 2B pseudogene (MZT2B pseudogene).